Showing 3611-3620 of 8824 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0309_06-php/22860/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0209_05-php/22877/Who's Responsible for Your Receivables?
https://practicaldermatology.com/topics/general-topics/PD0109_02-php/22889/When it comes to timely collection of payments, different staff members have important responsibilities.- HS Patients on Adalimumab Face Higher Risk of Serious Infections than PsO Counterpartshttps://practicaldermatology.com/news/hs-patients-on-adalimumab-face-higher-risk-of-serious-infections-than-pso-counterparts/2483028/Patients with hidradenitis suppurativa (HS) initiating adalimumab face a significantly higher risk of serious, noncutaneous infections requiring hospitalization compared with patients with psoriasis, a new cohort study finds.
- Study: AGE-Inhibitor Cream Improves Skin Tone and Firmness Post-Treatmenthttps://practicaldermatology.com/news/study-age-inhibitor-cream-improves-skin-tone-and-firmness-post-treatment/2483017/An AGE-inhibiting moisturizer significantly improved post-procedure facial appearance following glycolic acid peels or radiofrequency microneedling, particularly among women with skin of color. Researchers for the randomized,